Braincool Investor Relations Material

BrainCool AB is a Swedish medical device company specializing in the development, marketing, and sale of advanced medical cooling systems. The company focuses on targeted temperature management (TTM) solutions designed to protect the brain and vital organs by reducing metabolic activity and minimizing inflammation. These technologies are primarily applied in cases of cardiac arrest, stroke, and oncology-related complications such as oral mucositis caused by chemotherapy. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.